Trial Profile
A trial to compare the serum levels of the bio-chemical bone resorption marker CTX-I after antiresorptive drug administration such as zoledronic acid or denosumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Pharmacodynamics
- 20 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases